{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"1012.34016","value":"1097.50645"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"31"}],"units":"Participants"}],"description":"Serum concentration of alisertib on the seventh day of administration prior to the administration of the day 7 dose in nanograms/milliliter.","dispersionType":"Standard Deviation","groups":[{"description":"All patients.","id":"OG000","title":"All Patients"}],"paramType":"MEAN","populationDescription":"Of all eligible patients enrolled, 31 provided a seventh day of administration prior to the administration of the day 7 dose sample for analysis.","reportingStatus":"POSTED","timeFrame":"day 7 of protocol therapy","title":"Serum Concentration of Alisertib on the Seventh Day of Administration Prior to the Administration of the Day 7 Dose.","type":"SECONDARY","unitOfMeasure":"ng/ml"}